Background: Ischemic stroke is a common occurrence in patients with concomitant
malignancy. Systemic thrombolysis is often contraindicated in these patients, and …

The underlying aetiopathophysiology of cancer-related strokes and thromboembolisms
differs from that of noncancer-related strokes, which makes treating cancer-related strokes …

Background and Objectives Patients with a new diagnosis of cancer carry an increased risk
of acute ischemic stroke (AIS), and this risk varies depending on age, cancer type, stage …

Injury to the triangular fibrocartilage complex (TFCC) is one of the most common
complications following a fracture of the distal radius. In this study, an examination of TFCC …

Background Acute stroke patients with comorbid cancer (CC) are more preferably
addressed with endovascular treatment (EVT) than thrombolytic therapy, due to the …

Objectives Ischemic stroke and concurrent cancer is increasingly recognized. However,
optimal management is uncertain. As mechanical thrombectomy has become the standard …

Cancer can induce hypercoagulability, which may lead to stroke. This occurs when tumor
cells activate platelets as part of their growth and metastasis. Tumor cells activate platelets …

Background Large vessel occlusions (LVO) stroke is associated with cancer. Whether this
association differs among patients with LVO that undergo endovascular thrombectomy (EVT) …

Background Cancer is associated with an increased risk of acute ischemic stroke, including
large vessel occlusions. Whether cancer status affects outcomes in patients with large …

Background Active cancer (AC) is a known risk factor for stroke and a common comorbidity
among patients being considered for treatment with endovascular thrombectomy (EVT). This …